Current drug targets for antihyperlipidemic therapy

Area of Science:

• Biochemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Elevated lipid levels are a primary risk factor for atherosclerosis, cardiovascular diseases, and stroke, contributing significantly to mortality and morbidity.
• Lipid-lowering therapies are crucial for preventing coronary heart disease and stroke, yet current treatments face challenges.
• The need for novel antihyperlipidemic agents is driven by the limitations of existing drugs.

Purpose of the Study:

• To review recently identified and actively researched drug targets for antihyperlipidemic activity.
• To provide an overview of emerging strategies in the discovery of new lipid-lowering drugs.
• To consolidate information on 19 distinct targets currently under investigation.

Main Methods:

• Comprehensive literature search for recent research on antihyperlipidemic drug targets.
• Analysis and summarization of identified targets and their mechanisms.
• Review of ongoing research and development in novel antihyperlipidemic drug discovery.

Main Results:

• Nineteen novel drug targets for antihyperlipidemic therapy have been identified and are currently being explored.
• These targets represent diverse mechanisms for modulating lipid levels.
• The identified targets are the focus of worldwide research efforts to discover new drug leads.

Conclusions:

• Identifying and exploiting new drug targets is essential for overcoming the limitations of current antihyperlipidemic therapies.
• The reviewed targets offer promising avenues for the development of more effective treatments for hyperlipidemia and related cardiovascular conditions.
• Continued research into these nineteen targets is expected to yield novel drug candidates for antihyperlipidemic therapy.